Cipla Limited (NSE:CIPLA)

India · Delayed Price · Currency is INR

1,428.70

-8.00 (-0.56%)

May 15, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceutical and Related Products	277.12B	264.46B	248.42B	219.99B	213.51B
Pharmaceutical and Related Products Growth	4.78%	6.46%	12.92%	3.04%	13.10%
New Ventures	-	13.03B	11.12B	10.55B	5.32B
New Ventures Growth	-	17.24%	5.39%	98.46%	32.46%
Inter Segment Revenue	-	-2.02B	-1.80B	-3.01B	-1.19B
Total	277.12B	275.48B	257.74B	227.53B	217.63B
Total Growth	0.60%	6.88%	13.28%	4.55%	13.59%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
United States of America	78.99B	75.02B	59.09B	44.31B
United States of America Growth	5.30%	26.96%	33.34%	8.31%
Rest of The World	42.07B	37.33B	46.41B	48.72B
Rest of The World Growth	12.70%	-19.55%	-4.74%	-3.14%
India	116.15B	108.73B	98.69B	98.28B
India Growth	6.82%	10.18%	0.42%	27.04%
South Africa	38.26B	36.66B	23.35B	26.33B
South Africa Growth	4.38%	57.00%	-11.31%	14.33%
Total	275.48B	257.74B	227.53B	217.63B
Total Growth	6.88%	13.28%	4.55%	13.59%

Source: S&P Global Market Intelligence.